- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of COVID-19 In-Vitro Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of COVID-19 In-Vitro Diagnosticsmarket, defines the market attractiveness level of COVID-19 In-Vitro Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of COVID-19 In-Vitro Diagnostics industry, describes the types of COVID-19 In-Vitro Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global COVID-19 In-Vitro Diagnostics market and the development prospects and opportunities of COVID-19 In-Vitro Diagnostics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global COVID-19 In-Vitro Diagnostics market in Chapter 13.
By Player:
ADVAITE
Dynamiker Biotechnology (Tianjin)
Henry Schein
Abbott
Mayo Clinic Laboratories
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Roche
Safecare Bio-Tech
Guangdong Hecin-Scientific
Mount Sinai Laboratory
Cellex
BD
Guangzhou Wondfo Biotech
Ortho Clinical Diagnostics
BioMedomics
Chembio Diagnostics
By Type:
Rapid Diagnostic Test (RDT)
Enzyme Linked Immunosorbent Assay (ELISA)
Neutralization Assay
By End-User:
Home
Hospital
Clinical
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 COVID-19 In-Vitro Diagnostics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 COVID-19 In-Vitro Diagnostics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 COVID-19 In-Vitro Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 COVID-19 In-Vitro Diagnostics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise COVID-19 In-Vitro Diagnostics Market Analysis and Outlook to 2022
-
7.1 Global COVID-19 In-Vitro Diagnostics Consumption (2017-2022)
-
7.2 United States COVID-19 In-Vitro Diagnostics Consumption (2017-2022)
-
7.3 Europe COVID-19 In-Vitro Diagnostics Consumption (2017-2022)
-
7.4 China COVID-19 In-Vitro Diagnostics Consumption (2017-2022)
-
7.5 Japan COVID-19 In-Vitro Diagnostics Consumption (2017-2022)
-
7.6 India COVID-19 In-Vitro Diagnostics Consumption (2017-2022)
-
7.7 South Korea COVID-19 In-Vitro Diagnostics Consumption (2017-2022)
8 Region and Country-wise COVID-19 In-Vitro Diagnostics Market Analysis and Outlook to 2028
-
8.1 Global COVID-19 In-Vitro Diagnostics Consumption Forecast (2022-2028)
-
8.2 United States COVID-19 In-Vitro Diagnostics Consumption Forecast (2022-2028)
-
8.3 Europe COVID-19 In-Vitro Diagnostics Consumption Forecast (2022-2028)
-
8.4 China COVID-19 In-Vitro Diagnostics Consumption Forecast (2022-2028)
-
8.5 Japan COVID-19 In-Vitro Diagnostics Consumption Forecast (2022-2028)
-
8.6 India COVID-19 In-Vitro Diagnostics Consumption Forecast (2022-2028)
-
8.7 South Korea COVID-19 In-Vitro Diagnostics Consumption Forecast (2022-2028)
9 Global COVID-19 In-Vitro Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global COVID-19 In-Vitro Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Rapid Diagnostic Test (RDT) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Enzyme Linked Immunosorbent Assay (ELISA) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Neutralization Assay Consumption and Growth Rate (2017-2022)
-
9.2 Global COVID-19 In-Vitro Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Home Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinical Consumption and Growth Rate (2017-2022)
10 Global COVID-19 In-Vitro Diagnostics Market Outlook by Types and Applications to 2028
-
10.1 Global COVID-19 In-Vitro Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Rapid Diagnostic Test (RDT) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Enzyme Linked Immunosorbent Assay (ELISA) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Neutralization Assay Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global COVID-19 In-Vitro Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Home Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinical Consumption Forecast and Growth Rate (2022-2028)
11 Global COVID-19 In-Vitro Diagnostics Import and Export Analysis (Top 5 Countries)
-
11.1 Global COVID-19 In-Vitro Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global COVID-19 In-Vitro Diagnostics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 COVID-19 In-Vitro Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global COVID-19 In-Vitro Diagnostics Market Competitive Analysis
-
14.1 ADVAITE
-
14.1.1 ADVAITE Company Details
-
14.1.2 ADVAITE COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 ADVAITE COVID-19 In-Vitro Diagnostics Product and Service
-
14.2 Dynamiker Biotechnology (Tianjin)
-
14.2.1 Dynamiker Biotechnology (Tianjin) Company Details
-
14.2.2 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product and Service
-
14.3 Henry Schein
-
14.3.1 Henry Schein Company Details
-
14.3.2 Henry Schein COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Henry Schein COVID-19 In-Vitro Diagnostics Product and Service
-
14.4 Abbott
-
14.4.1 Abbott Company Details
-
14.4.2 Abbott COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Abbott COVID-19 In-Vitro Diagnostics Product and Service
-
14.5 Mayo Clinic Laboratories
-
14.5.1 Mayo Clinic Laboratories Company Details
-
14.5.2 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product and Service
-
14.6 Zhejiang Orient Gene Biotech
-
14.6.1 Zhejiang Orient Gene Biotech Company Details
-
14.6.2 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product and Service
-
14.7 Innovita Biological Technology
-
14.7.1 Innovita Biological Technology Company Details
-
14.7.2 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product and Service
-
14.8 Roche
-
14.8.1 Roche Company Details
-
14.8.2 Roche COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Roche COVID-19 In-Vitro Diagnostics Product and Service
-
14.9 Safecare Bio-Tech
-
14.9.1 Safecare Bio-Tech Company Details
-
14.9.2 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product and Service
-
14.10 Guangdong Hecin-Scientific
-
14.10.1 Guangdong Hecin-Scientific Company Details
-
14.10.2 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product and Service
-
14.11 Mount Sinai Laboratory
-
14.11.1 Mount Sinai Laboratory Company Details
-
14.11.2 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product and Service
-
14.12 Cellex
-
14.12.1 Cellex Company Details
-
14.12.2 Cellex COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Cellex COVID-19 In-Vitro Diagnostics Product and Service
-
14.13 BD
-
14.13.1 BD Company Details
-
14.13.2 BD COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 BD COVID-19 In-Vitro Diagnostics Product and Service
-
14.14 Guangzhou Wondfo Biotech
-
14.14.1 Guangzhou Wondfo Biotech Company Details
-
14.14.2 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product and Service
-
14.15 Ortho Clinical Diagnostics
-
14.15.1 Ortho Clinical Diagnostics Company Details
-
14.15.2 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product and Service
-
14.16 BioMedomics
-
14.16.1 BioMedomics Company Details
-
14.16.2 BioMedomics COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 BioMedomics COVID-19 In-Vitro Diagnostics Product and Service
-
14.17 Chembio Diagnostics
-
14.17.1 Chembio Diagnostics Company Details
-
14.17.2 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of COVID-19 In-Vitro Diagnostics
-
Figure COVID-19 In-Vitro Diagnostics Picture
-
Table Global COVID-19 In-Vitro Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global COVID-19 In-Vitro Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global COVID-19 In-Vitro Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global COVID-19 In-Vitro Diagnostics Consumption by Country (2017-2022)
-
Figure United States COVID-19 In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe COVID-19 In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure China COVID-19 In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan COVID-19 In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India COVID-19 In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea COVID-19 In-Vitro Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global COVID-19 In-Vitro Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States COVID-19 In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe COVID-19 In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China COVID-19 In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan COVID-19 In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India COVID-19 In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea COVID-19 In-Vitro Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rapid Diagnostic Test (RDT) Consumption and Growth Rate (2017-2022)
-
Figure Global Enzyme Linked Immunosorbent Assay (ELISA) Consumption and Growth Rate (2017-2022)
-
Figure Global Neutralization Assay Consumption and Growth Rate (2017-2022)
-
Figure Global Home Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinical Consumption and Growth Rate (2017-2022)
-
Figure Global Rapid Diagnostic Test (RDT) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzyme Linked Immunosorbent Assay (ELISA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neutralization Assay Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinical Consumption Forecast and Growth Rate (2022-2028)
-
Table Global COVID-19 In-Vitro Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global COVID-19 In-Vitro Diagnostics Export by Region (Top 5 Countries) (2017-2028)
-
Table ADVAITE (Foundation Year, Company Profile and etc.)
-
Table ADVAITE COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ADVAITE COVID-19 In-Vitro Diagnostics Product and Service
-
Table Dynamiker Biotechnology (Tianjin) (Foundation Year, Company Profile and etc.)
-
Table Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product and Service
-
Table Henry Schein (Foundation Year, Company Profile and etc.)
-
Table Henry Schein COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Henry Schein COVID-19 In-Vitro Diagnostics Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott COVID-19 In-Vitro Diagnostics Product and Service
-
Table Mayo Clinic Laboratories (Foundation Year, Company Profile and etc.)
-
Table Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product and Service
-
Table Zhejiang Orient Gene Biotech (Foundation Year, Company Profile and etc.)
-
Table Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product and Service
-
Table Innovita Biological Technology (Foundation Year, Company Profile and etc.)
-
Table Innovita Biological Technology COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche COVID-19 In-Vitro Diagnostics Product and Service
-
Table Safecare Bio-Tech (Foundation Year, Company Profile and etc.)
-
Table Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product and Service
-
Table Guangdong Hecin-Scientific (Foundation Year, Company Profile and etc.)
-
Table Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product and Service
-
Table Mount Sinai Laboratory (Foundation Year, Company Profile and etc.)
-
Table Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product and Service
-
Table Cellex (Foundation Year, Company Profile and etc.)
-
Table Cellex COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cellex COVID-19 In-Vitro Diagnostics Product and Service
-
Table BD (Foundation Year, Company Profile and etc.)
-
Table BD COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table BD COVID-19 In-Vitro Diagnostics Product and Service
-
Table Guangzhou Wondfo Biotech (Foundation Year, Company Profile and etc.)
-
Table Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product and Service
-
Table Ortho Clinical Diagnostics (Foundation Year, Company Profile and etc.)
-
Table Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product and Service
-
Table BioMedomics (Foundation Year, Company Profile and etc.)
-
Table BioMedomics COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMedomics COVID-19 In-Vitro Diagnostics Product and Service
-
Table Chembio Diagnostics (Foundation Year, Company Profile and etc.)
-
Table Chembio Diagnostics COVID-19 In-Vitro Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product and Service
-

Chinese